Pelthos Therapeutics Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-3.02 | $-6.62 | -119.2% | Miss |
| Q12026 FY2026 | $4.00 | $-3.09 | -177.3% | Miss |
| Q42025 FY2025 | $-3.95 | $-2.83 | +28.4% | Beat |
Back to PTHS overview · PTHS holders · PTHS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.